Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2003
10/16/2003WO2003084337A1 Triglyceride fat
10/16/2003WO2003068809A3 An herpes simplex virus complex
10/16/2003WO2003068247B1 Eye installation based on iodine anions
10/16/2003WO2003066030A3 Pharmaceutical tablet
10/16/2003WO2003066029A3 Pharmaceutical dosage form for mucosal delivery
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003059246A3 Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
10/16/2003WO2003057650A3 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
10/16/2003WO2003047493A3 Stabilized reverse micelle compositions and uses thereof
10/16/2003WO2003043668A3 Conditioning solution for contact lenses
10/16/2003WO2003037314A3 Medical compositions for intravesical treatment of bladder cancer
10/16/2003WO2003037159A3 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
10/16/2003WO2003035790A3 Improved method for generating an aerosol
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003032922A3 Stabilized azithromycin compositions
10/16/2003WO2003031581A3 Thioester-terminated water soluble polymers and method of modifying the n-terminus of a polypeptide therewith
10/16/2003WO2003028634A3 Method of treatment using ligand-immunogen conjugates
10/16/2003WO2003027250A3 Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
10/16/2003WO2003026743A3 Opioid formulations having reduced potential for abuse
10/16/2003WO2003026626A3 Modified release dosage forms
10/16/2003WO2003026492A3 Prevention and treatment of restenosis by local administration of drug
10/16/2003WO2003022997A3 Human tissue urokinase type plasminogen activator formulation
10/16/2003WO2003022260B1 Use of methotrexate and l-arginine for the preparation of a medicament for treatment of uterine myoma
10/16/2003WO2003022218A3 Carboxylate-gated-nitroxide (cgn) compounds and compositions and methods of use thereof
10/16/2003WO2003020241A3 Functional powders for oral delivery
10/16/2003WO2003018609A3 Application of peptide conjugates to alzheimer's disease
10/16/2003WO2003011342A3 Targeted polymeric delivery systems
10/16/2003WO2003011247A3 Support matrix comprising particles loaded with active ingredient for application on the skin or mucous membrane
10/16/2003WO2003011211A3 Peg-modified uricase
10/16/2003WO2002100382A3 Controlled release dosage forms using acrylic polymer, and process for making the same
10/16/2003WO2002100347A3 Prodrugs of gaba analogs, compositions and uses thereof
10/16/2003WO2002085299A3 Therapeutic treatments using the direct application of antimicrobial metal compositions
10/16/2003WO2002080884A3 Powder inhaler formulations
10/16/2003WO2002066066A9 Terminally-branched polymeric linkers and polymeric conjugates containing the same
10/16/2003WO2002055101A9 Storage stable powder compositions of interleukin-4 receptor
10/16/2003WO2002034304A9 Self-adhesive hydratable matrix for topical therapeutic use
10/16/2003WO2002007739A9 Pharmaceutical preparation for the treatment and diagnosis of tumors and method for the preparation of the lipid free fraction of blood plasma
10/16/2003WO2002007673A3 Calcilytic compounds
10/16/2003US20030195228 Pharmaceutical compositions for hepatitis C viral protease inhibitors
10/16/2003US20030195225 Acidification of drugs such as carbendazim, by mixing with buffers improving water solubility; anticarcinogenic agents
10/16/2003US20030195220 Preparations for oral administration
10/16/2003US20030195214 Cancer treatment
10/16/2003US20030195179 Redispersibility comprising polyvinylpyrrolidone and a water-soluble anionic macromolecular compound which are added to prevent a hardly soluble drug from adhering to a container and forming aggregates
10/16/2003US20030195178 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof
10/16/2003US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs
10/16/2003US20030195154 Comprises mimetics of erythropoietin, thrombopoietin, and glucagon-like peptide conjugated to polymer
10/16/2003US20030195152 Polymeric conjugates of antitumor agents
10/16/2003US20030195150 Antimicrobial peptides
10/16/2003US20030195144 Antimicrobial compounds and formulations
10/16/2003US20030195142 Formulated composition
10/16/2003US20030195133 For delivery of fragrances and other active ingredients onto fabric, hair, skin, and other biological surfaces and which provides prolonged release of active ingredients or yields high impact fragrance "burst" upon treatment
10/16/2003US20030194803 Antigen-presenting cell populations and their use as reagents for enhancing or reducing immune tolerance
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194762 Use making a claimed cyclotetrasaccharide of glucose units; use as filler, stabilizer, sweetener among other things in drugs, cosmetics and foods
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194456 Extract of the leaves and/or stem of Argemone mexicana plant for treatment of psoriasis and related biochemical and immunological disorders
10/16/2003US20030194452 Improved herbal composition having antiallergic properties and a process for the preparation thereof
10/16/2003US20030194447 Antiseptic compositions and methods
10/16/2003US20030194444 Methods of treating skin and integument conditions
10/16/2003US20030194443 External solid phase containing a polyhydroxyalkanoate and an internal phase that is a second solid phase, a liquid phase or a gaseous phase; drugs, agricultural products, cosmetics
10/16/2003US20030194442 Insoluble drug particle compositions with improved fasted-fed effects
10/16/2003US20030194441 Antibacterial aqueous solutioncomprises: methylcellulose; citric acid; polyethylene glycol and an active drug component, especially a quinolone antibiotic; viscosity of 12 mPa.s or below at 20 degrees C.
10/16/2003US20030194440 Pharmaceutical composition for sustained release of the hmg-coa reductase inhibitor fluvastatin
10/16/2003US20030194439 Pharmaceutical dosage form for pulsatile delivery of methylphenidate
10/16/2003US20030194438 Ionically bound to hyaluronic acid, poly-gamma-glutamic acid or other ionic polymers, utilizing counter-ions of different valences to control the rate of release into the body.
10/16/2003US20030194434 Bubbling tablet, bubbling bath additive tablet, bubbling washing detergent tablet, bubbling tablet for oral administration, and process for producing these
10/16/2003US20030194415 Film-forming compositions and methods
10/16/2003US20030194378 Novel aerosol formulation containing a polar fluorinated molecule
10/16/2003US20030194377 Therapeutic uses of BPI protein products in cystic fibrosis patients
10/16/2003US20030193102 Encapsulated agglomeration of microcapsules and method for the preparation thereof
10/16/2003CA2708900A1 Pharmaceutical preparation containing oxycodone and naloxone
10/16/2003CA2481334A1 Tissue-specific endothelial membrane proteins
10/16/2003CA2481025A1 Palatable chewable tablet
10/16/2003CA2480824A1 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin
10/16/2003CA2480811A1 Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
10/16/2003CA2480052A1 Antibodies that specifically bind to gmad
10/16/2003CA2479810A1 Polymeric acyl derivatives of indoles
10/16/2003CA2479781A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/16/2003CA2479522A1 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
10/16/2003CA2479520A1 P38 kinase inhibitors for treating mucus hypersecretion_
10/16/2003CA2479380A1 Hydrogel adhesives for use on hair or fiber-populated surfaces
10/16/2003CA2478523A1 Matrix for sustained, invariant and independent release of active compounds
10/16/2003CA2477935A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2452442A1 Polyfunctional biocompatible hydrogel and method for the production thereof
10/15/2003EP1352955A2 HLA matching donor-originating activated lymphocytes to be used in prevention/treatment of tumors, infectious diseases and autoimmune diseases, treatment method achieved by using the lymphocytes, formula having the lymphocytes as a main constitutuent thereof, method for manufacturing the formula and preparation kit to be used to prepare the formula
10/15/2003EP1352662A1 Conjugates of an antibody and a water-soluble polymer used in immunoliposomes
10/15/2003EP1352661A1 Injections for endoscopy
10/15/2003EP1352654A1 Famotidine injections
10/15/2003EP1352647A1 Controlled-release sedative hypnotic compositions and method related thereto
10/15/2003EP1352646A2 Lozenge containing ambroxol
10/15/2003EP1352638A1 Cosmetics
10/15/2003EP1352077A2 Materials and methods relating to protein aggregation in neurodegenerative disease
10/15/2003EP1352073A2 Electrically responsive promoter system
10/15/2003EP1352072A2 Nucleic acid delivery formulations
10/15/2003EP1352070A2 A fibrin/fibrinogen-binding conjugate
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1352061A2 Method for inhibiting the expression of a target gene
10/15/2003EP1352056A2 Polypeptides
10/15/2003EP1351991A2 Ternary biomolecule/polymer/surface-based immobilization systems
10/15/2003EP1351980A2 Peptides for activation and inhibition of delta pkc
1 ... 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 ... 1712